Eudaimonia Partners, LLC Sorrento Therapeutics, Inc. Transaction History

Eudaimonia Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$6.35 - $10.0 $12,700 - $20,000	-2,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$7.03 - $16.51 $14,060 - $33,020	2,000 New	2,000 $17,000
Q4 2020 Feb 18, 2021	SELL	$5.76 - $11.95 $11,520 - $23,900	-2,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$6.17 - $18.82 $12,340 - $37,640	2,000 New	2,000 $22,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Eudaimonia Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Eudaimonia Partners, LLC with notifications on news.